Startups
Biotechnology / Education / Incubators / Investing / Startups

UMB BioPark biotech company Noxilizer expands to Europe

The company "manufactures sterilization technology for medical devices and equipment."

Noxilizer CEO Lawrence Bruder, left, with Maryland Governor Martin O'Malley. Photo courtesy of the UMB Elm.

Biotech company Noxilizer, based out of the University of Maryland BioPark, has set up a sales operation in Europe.
The company, which “manufactures sterilization technology for medical devices and equipment,” announced in a press release that its expansion to Europe “is intended to accelerate the global acceptance of nitrogen dioxide sterilization as a powerful, efficient, and cost-saving alternative to traditional sterilization methods.”
Read more at Noxilizer.

Companies: Noxilizer / University of Maryland BioPark
Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

How venture capital is changing, and why it matters

Why the DOJ chose New Jersey for the Apple antitrust lawsuit

A veteran ship's officer describes how captains work with harbor pilots to avoid deadly collisions

What we know so far about the Key Bridge collapse

Technically Media